|
KMO expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.054430E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.556200E-01 |
| Normal-vs-Stage2 |
5.315200E-01 |
| Normal-vs-Stage3 |
1.738130E-02 |
| Normal-vs-Stage4 |
3.282200E-01 |
| Stage1-vs-Stage2 |
9.191000E-01 |
| Stage1-vs-Stage3 |
5.789900E-02 |
| Stage1-vs-Stage4 |
5.756200E-01 |
| Stage2-vs-Stage3 |
1.615220E-01 |
| Stage2-vs-Stage4 |
7.312600E-01 |
| Stage3-vs-Stage4 |
3.368800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.381700E-02 |
| Normal-vs-AfricanAmerican |
3.659400E-01 |
| Normal-vs-Asian |
4.220500E-02 |
| Caucasian-vs-AfricanAmerican |
4.342200E-03 |
| Caucasian-vs-Asian |
1.638270E-03 |
| AfricanAmerican-vs-Asian |
1.946220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.172630E-01 |
| Normal-vs-Female |
2.226600E-01 |
| Male-vs-Female |
7.264400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.732800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.607570E-01 |
| Normal-vs-Age(61-80Yrs) |
2.751200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.072600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.557200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.863200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.642600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.371000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.194200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.020200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.862800E-01 |
| Normal-vs-Grade 2 |
2.312600E-01 |
| Normal-vs-Grade 3 |
1.424950E-01 |
| Normal-vs-Grade 4 |
9.678400E-02 |
| Grade 1-vs-Grade 2 |
4.435800E-02 |
| Grade 1-vs-Grade 3 |
2.862100E-02 |
| Grade 1-vs-Grade 4 |
1.996020E-02 |
| Grade 2-vs-Grade 3 |
6.459400E-01 |
| Grade 2-vs-Grade 4 |
4.143200E-01 |
| Grade 3-vs-Grade 4 |
6.932400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.094400E-01 |
| Normal-vs-ccB subtype |
4.000400E-03 |
| ccA subtype-vs-ccB subtype |
1.796230E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.234300E-02 |
| Normal-vs-N1 |
4.591200E-01 |
| N0-vs-N1 |
8.892000E-01 |
|
|
